APA (7th ed.) Citation

Bruno, R., Chanu, P., Kågedal, M., Mercier, F., Yoshida, K., Guedj, J., . . . Jin, J. Y. (2023). Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models. British Journal of Cancer, 129(9), 1383. https://doi.org/10.1038/s41416-023-02190-5

Chicago Style (17th ed.) Citation

Bruno, René, Pascal Chanu, Matts Kågedal, Francois Mercier, Kenta Yoshida, Jérémie Guedj, Chunze Li, Ulrich Beyer, and Jin Y. Jin. "Support to Early Clinical Decisions in Drug Development and Personalised Medicine with Checkpoint Inhibitors Using Dynamic Biomarker-overall Survival Models." British Journal of Cancer 129, no. 9 (2023): 1383. https://doi.org/10.1038/s41416-023-02190-5.

MLA (9th ed.) Citation

Bruno, René, et al. "Support to Early Clinical Decisions in Drug Development and Personalised Medicine with Checkpoint Inhibitors Using Dynamic Biomarker-overall Survival Models." British Journal of Cancer, vol. 129, no. 9, 2023, p. 1383, https://doi.org/10.1038/s41416-023-02190-5.